ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PDLI PDL BioPharma Inc

2.47
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
PDL BioPharma Inc NASDAQ:PDLI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.47 2.62 2.63 0 01:00:00

PDL BioPharma to Participate in the Cowen and Company 40th Annual Health Care Conference

25/02/2020 1:30pm

PR Newswire (US)


PDL BioPharma (NASDAQ:PDLI)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more PDL BioPharma Charts.

INCLINE VILLAGE, Nev., Feb. 25, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces that Dominique Monnet, PDL's president and chief executive officer, will present at the Cowen and Company 40th Annual Health Care Conference on Tuesday, March 3, 2020 at 10:40 a.m. Eastern time (7:40 a.m. Pacific time). The conference is being held at the Boston Marriott Copley Place.

To access the live and subsequently archived webcast of the presentation, visit the Company's website at https://www.pdl.com/, go to the Investor Relations section and select "Events & Presentations." Please connect to the website at least 15 minutes prior to the presentation to allow for any software download that may be necessary. The archived webcast will be available for at least seven days following the presentation. 

About PDL BioPharma, Inc.
Throughout its history, PDL's mission has been to improve the lives of patients by aiding in the successful development of innovative therapeutics and healthcare technologies. PDL BioPharma was founded in 1986 as Protein Design Labs, Inc. when it pioneered the humanization of monoclonal antibodies, enabling the discovery of a new generation of targeted treatments that have had a profound impact on patients living with different cancers as well as a variety of other debilitating diseases. In 2006, the Company changed its name to PDL BioPharma, Inc.

As of December 2019, PDL ceased making additional strategic transactions and investments and is pursuing a formal process to unlock the value of its portfolio by monetizing its assets and ultimately distributing net proceeds to shareholders.

For more information please visit https://www.pdl.com/.

NOTE:  PDL, PDL BioPharma, the PDL logo and associated logos and the PDL BioPharma logo are trademarks or registered trademarks of, and are proprietary to, PDL BioPharma, Inc. which reserves all rights therein.

PDL BioPharma, Inc. (PRNewsFoto/PDL BioPharma, Inc.)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-to-participate-in-the-cowen-and-company-40th-annual-health-care-conference-301008917.html

SOURCE PDL BioPharma, Inc.

Copyright 2020 PR Newswire

1 Year PDL BioPharma Chart

1 Year PDL BioPharma Chart

1 Month PDL BioPharma Chart

1 Month PDL BioPharma Chart

Your Recent History

Delayed Upgrade Clock